AnalystBook Research · Company Intelligence

STEPAN CO

SCLNYSE

Built from STEPAN CO's own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

STEPAN CO: Revenue grew 7% to $2.332B from $2.18B. Net income declined 6.9% to $46.9M from $50.37M. Free cash flow declined 35.4% to $25.37M from $39.28M. Operating margin expanded 14 bps to 3.37%. STEPAN CO's annual comparison also shows free cash flow declined despite revenue growth; margins improved while free cash flow declined; stock compensation grew faster than revenue.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue grew 7% to $2.332B from $2.18BOK
  • ProfitabilityNet income declined 6.9% to $46.9M from $50.37MWatch
  • Cash flowFree cash flow declined 35.4% to $25.37M from $39.28MWatch
  • MarginsOperating margin expanded 14 bps to 3.37%OK
  • AccountingNo overriding statistical warningNote
  • Insiders0 purchases and 2 salesWatch

Business

We depend on our highly skilled workforce to reach our business goals, and through a robust commitment to promote safety and well-being, enable professional development, and provide competitive benefits, the Company aims to attract and retain top talent.

Where the revenue comes from

Fiscal 2025, as STEPAN CO reports it. History and quarterly detail are in the app.

  • Surfactants$1.7B
  • Polymers$584.5M
  • Specialty Products$81.7M

Leadership changes

From STEPAN CO's own filings, the day they're filed.

  • Samuel S. Hinrichsen · President · appointmenteff. 2025-10-31
  • Samuel Hinrichsen · Chief Financial Officer · appointmenteff. 2025-07-15
  • Ruben Velasquez · President · appointmenteff. 2025-07-15

Latest filings

  • 10-Q · Quarterly report2026-08-05
  • 8-K · Company announcement2026-07-29
  • 10-Q · Quarterly report2026-05-06
  • 8-K · Company announcement2026-04-30
  • 8-K · Company announcement2026-04-28
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about STEPAN CO, every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.